Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV001033117 | SCV001196424 | likely pathogenic | Glycogen storage disease type III | 2019-10-01 | criteria provided, single submitter | clinical testing | This variant is a sub-genic deletion of the genomic region encompassing exons 34 of the AGL gene. While this deletion is not anticipated to result in nonsense mediated decay, it is expected to create a truncated protein product. This variant has been observed in individual(s) with glycogen storage disease type III (Invitae). In at least one individual the data is consistent with the variant being in trans (on the opposite chromosome) from a pathogenic variant. In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic. |